James M. Scheiman

15.4k total citations · 1 hit paper
264 papers, 9.0k citations indexed

About

James M. Scheiman is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, James M. Scheiman has authored 264 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Surgery, 75 papers in Pulmonary and Respiratory Medicine and 75 papers in Oncology. Recurrent topics in James M. Scheiman's work include Helicobacter pylori-related gastroenterology studies (68 papers), Inflammatory mediators and NSAID effects (67 papers) and Pancreatic and Hepatic Oncology Research (66 papers). James M. Scheiman is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (68 papers), Inflammatory mediators and NSAID effects (67 papers) and Pancreatic and Hepatic Oncology Research (66 papers). James M. Scheiman collaborates with scholars based in United States, Spain and Canada. James M. Scheiman's co-authors include Grace H. Elta, Francis K.L. Chan, Neena S. Abraham, Timothy T. Nostrant, David A. Johnson, Eamonn M.M. Quigley, Ángel Lanas, Curt D. Furberg, Elliott M. Antman and Kenneth W. Mahaffey and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

James M. Scheiman

260 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

2008 641 citations Deepak L. Bhatt, James M. Scheiman et al. Circulation profile →

Peers

Countries citing papers authored by James M. Scheiman

Since Specialization

Citations

This map shows the geographic impact of James M. Scheiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Scheiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Scheiman more than expected).

Fields of papers citing papers by James M. Scheiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Scheiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Scheiman. The network helps show where James M. Scheiman may publish in the future.

Co-authorship network of co-authors of James M. Scheiman

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Scheiman. A scholar is included among the top collaborators of James M. Scheiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Scheiman. James M. Scheiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Needle-compatible miniaturized optoelectronic sensor for pancreatic cancer detection 2020 ·Science Advances ·Seung Yup Lee, (unknown), Kyounghwan Na, Jiaqi Shi, Barbara J. McKenna, Diane M. Simeone, Euisik Yoon, James M. Scheiman, Mary‐Ann Mycek	13
2	Missed opportunities to prevent upper GI hemorrhage: The experience of the Michigan Anticoagulation Quality Improvement Initiative 2019 ·Vascular Medicine ·Jacob E. Kurlander, Xiaokui Gu, James M. Scheiman, Brian Haymart, Eva Kline‐Rogers, Sameer D. Saini, Scott Kaatz, James B. Froehlich, Caroline R. Richardson, Geoffrey D. Barnes	10
3	Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States 2019 ·Clinical Gastroenterology and Hepatology ·Anna Tavakkoli, Amit G. Singal, Akbar K. Waljee, B. Joseph Elmunzer, Sandi L. Pruitt, (unknown), Joel H. Rubenstein, James M. Scheiman, Caitlin C. Murphy	77
4	The Right Idea for the Wrong Patient: Results of a National Survey on Stopping PPIs 2017 ·Clinical Gastroenterology and Hepatology ·Jacob E. Kurlander, (unknown), James M. Scheiman, Arlene Weissman, John D. Piette, Joel H. Rubenstein, Akbar K. Waljee, Sameer D. Saini	6
5	Long‐Term Safety of a Coordinated Delivery Tablet of Enteric‐Coated Aspirin 325 mg and Immediate‐Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk 2016 ·Cardiovascular Therapeutics ·Jay L. Goldstein, David J. Whellan, James M. Scheiman, Byron Cryer, Glenn M. Eisen, Ángel Lanas, John G. Fort	7
6	Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy 2015 ·Cancer Prevention Research ·Ronald A. Lubet, James M. Scheiman, Ann M. Bode, Jonathan M. White, Lori M. Minasian, M. Margaret Juliana, Daniel Boring, Vernon E. Steele, Clinton J. Grubbs	13
7	Evaluation and Management of the Atrial Fibrillation Patient 2013 ·Critical Pathways in Cardiology A Journal of Evidence-Based Medicine ·Benjamin A. Steinberg, P. Beckley, Thomas F. Deering, Carol L. Clark, Alpesh Amin, Kenneth A. Bauer, Byron Cryer, Moussa Mansour, James M. Scheiman, Marco A. Zenati, L. Kristin Newby, W. Frank Peacock, Deepak L. Bhatt	3
8	Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial ( CONDOR ) 2012 ·Alimentary Pharmacology & Therapeutics ·Ángel Lanas, Jay L. Goldstein, Francis K.L. Chan, C. Mel Wilcox, David A. Peura, (unknown), Gina Sands, James M. Scheiman	29
9	Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy 2012 ·Heart ·Rubén Casado-Arroyo, Mónica Polo-Tomás, (unknown), James M. Scheiman, Ángel Lanas	57
10	Underutilization of gastroprotection for at‐risk patients undergoing percutaneous coronary intervention: Spain compared with the United States 2010 ·Alimentary Pharmacology & Therapeutics ·Rubén Casado-Arroyo, James M. Scheiman, Mónica Polo-Tomás, Sameer D. Saini, Alfonso del Río, (unknown), Ángel Lanas	12
11	ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use breakdown → 2008 ·Circulation ·Deepak L. Bhatt, James M. Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K.L. Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M.M. Quigley	641
12	Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents 2008 ·The American Journal of Gastroenterology ·Francis K.L. Chan, Neena S. Abraham, James M. Scheiman, Loren Laine, (unknown)	124
13	Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors 2005 ·The American Journal of Gastroenterology ·C J Hawkey, Nicholas J. Talley, Neville D. Yeomans, Roger Jones, Joseph J.�Y. Sung, Göran Långström, J. Næsdal, James M. Scheiman	75
14	Making Cost-Effectiveness Analyses Clinically Relevant 2003 ·Academic Radiology ·Ruth C. Carlos, James M. Scheiman, Hero K. Hussain, Julie H. Song, Isaac R. Francis, A. Mark Fendrick	20
15	The Impact of Nonsteroidal Anti-Inflammatory Drug-Induces Gastropathy 2001 ·The American Journal of Managed Care ·James M. Scheiman	1
16	Routine droperidol pre-medication improves sedation for ERCP 2000 ·Gastrointestinal Endoscopy ·(unknown), Jeffrey L. Barnett, William D. Chey, James M. Scheiman, Grace H. Elta	16
17	Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current 1998 ·Gastrointestinal Endoscopy ·Grace H. Elta, Jeffrey L. Barnett, (unknown), Kimberly Brown, (unknown), James M. Scheiman	85
18	Reduction of non-steroidal anti-inflammatory drug induced gastric injury and leucocyte endothelial adhesion by octreotide. 1997 ·Gut ·James M. Scheiman, (unknown), (unknown), (unknown), Sabine Angermüller, (unknown), G. Engel, K. H. Usadel, Klaus Kusterer	20
19	NSAIDS, GASTROINTESTINAL INJURY, AND CYTOPROTECTION 1996 ·Gastroenterology Clinics of North America ·James M. Scheiman	120
20	A calibration technique for a hot-wire-probe vector anemometer 1982 ·NASA STI/Recon Technical Report N ·James M. Scheiman, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact